Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism | Zendy

Hiroki Takata | Zendy; Hiroyuki Yamada | Zendy; Hiroyuki Kawahito | Zendy; Sou Kishida | Zendy; Daisuke Irie | Zendy; Taku Kato | Zendy; Noriyuki Wakana | Zendy; Sonoko Miyagawa | Zendy; Kensuke Fukui | Zendy; Hiroaki Matsubara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism

Author(s) -

Hiroki Takata,

Hiroyuki Yamada,

Hiroyuki Kawahito,

Sou Kishida,

Daisuke Irie,

Taku Kato,

Noriyuki Wakana,

Sonoko Miyagawa,

Kensuke Fukui,

Hiroaki Matsubara

Publication year - 2013

Publication title -

journal of the renin-angiotensin-aldosterone system

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.457

H-Index - 46

eISSN - 1752-8976

pISSN - 1470-3203

DOI - 10.1177/1470320313491794

Subject(s) - kinin , mechanism (biology) , angiotensin ii , receptor , angiotensin ii receptor type 1 , chemistry , medicine , endocrinology , pharmacology , bradykinin , physics , quantum mechanics

The angiotensin II (Ang II) type 1 receptor exerts pro-atherogenic action by augmenting oxidative stress, whereas the Ang II type 2 receptor (AT2)-mediated effect on atherosclerosis remains controversial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research